摘要
目的探讨影响阿托品试验结果的年龄性别特征。方法选取2013年7月―2016年7月,接诊的静息状态下常规12导心电图诊断,窦性心动过缓112例,进行阿托品试验,分男女两组,男组66例,女组46例,静脉注射阿托品后即刻、1分、3分、5分、10分、15分、20分别描计心电图计算心率,以阿托品试验结果分析两组性别、年龄特征。结果 59例阳性、53例阴性,阳性患者平均年龄60.9岁高于阴性患者平均年龄52.94岁,P<0.05。男组阳性患者平均年龄60.74岁,高于男组阴性患者平均年龄52.89岁;女组阳性患者平均年龄61.07岁,高于女组阴性患者平均年龄53.06岁。男组阳性率46.97%,女组阳性率60.87%,女组阳性率高于男组,P<0.05。结论心电图阿托品试验结果与年龄、性别有关。
Objective To explore the age and sex characteristics that affect atropine trial results. Methods From July 2013 to July 2016, routine 12-lead electrocardiogram diagnosis was performed in the resting state of the patients, 112 cases of sinus bradycardia were tested for atropine. There were 66 cases in the male group and 46 in the female group. Immediately after intravenous injection of atropine, 1, 3, 5, 10, 15, 20 minutes, respectively, calculated the heart rate by ECG. The sex and age characteristics of the two groups were analyzed with atropine test results. Results 59 cases were positive and 53 cases were negative. The average age of positive patients was 60.9 years old higher than the negative patients of 52.94 years old, P〈0.05. The average age of male positive patients was 60.74 years old, higher than the average age of male negative patients 52.89. The average age of female positive patients was 61.07 years old, higher than the average age of female negative patients 53.06. The positive rate of female group was 60.87% higher than that of male group 46.97%, P〈0.05. Conclusion Ecg atropine test results were related to age and sex.
作者
陈玉先
CHEN Yu-xian(Jizhong Energy Xingtai Mining Group Co., Ltd. General Hospital, Xingtai, Hebei, 05400)
出处
《智慧健康》
2018年第5期7-9,共3页
Smart Healthcare
